Suppr超能文献

患有精神疾病的老年人的药物负担指数:一项横断面研究。

Drug Burden Index in Older Adults with Psychiatric Illnesses: A Cross-Sectional Study.

作者信息

Chahine Bahia

机构信息

PharmD Program, School of Pharmacy, Lebanese International University, Beirut, Lebanon.

出版信息

Drugs Real World Outcomes. 2023 Jun;10(2):283-290. doi: 10.1007/s40801-023-00357-3. Epub 2023 Mar 13.

Abstract

BACKGROUND

Medications with anticholinergic and/or sedative properties are commonly used in the management of psychiatric illnesses. The burden of anticholinergic and sedative medication use has been measured by the Drug Burden Index (DBI) score tool. A higher DBI score has been associated with increased risk of falls, bone and hip fractures, and functional and cognitive impairment, among other serious health outcomes, especially in older adults.

OBJECTIVES

We aimed to describe the drug burden in older adults with psychiatric illnesses using DBI, determine the factors that are associated with the drug burden measured by DBI, and examine the association between DBI score and Katz for activities of daily living (ADL) index.

METHODS

A cross-sectional study was conducted in the psychogeriatric division of an aged-care home. The study sample comprised all inpatients, aged ≥ 65 years, diagnosed with psychiatric illness. The data obtained included demographic characteristics, duration of hospital stay, primary psychiatric diagnosis and comorbidities, functional status using the Katz ADL index, and cognitive status using the Mini-Mental State Examination (MMSE) score. DBI score was calculated for each anticholinergic and sedative medication used.

RESULTS

Of the 200 patients eligible for analysis, 106 (53.1%) were females and the mean age was 76 ± 9 years. The most commonly encountered chronic disorders were hypertension 102 (51%) and schizophrenia 94 (47%). The use of drugs with anticholinergic and/or sedative effects was seen in 163 (81.5%) patients; the mean DBI score was 1.25 ± 1. The results of the multinomial logistic regression showed that schizophrenia (odds ratio (OR) = 2.1 (95% confidence interval (CI) 1.57-4.45), p = 0.01), level of dependency (OR = 3.50 (95% CI 1.38-5.70), p = 0.001), and polypharmacy (OR = 2.99 (95% CI 2.15-4.29), p = 0.003) were significantly associated with DBI score ≥ 1 compared to DBI score 0.

CONCLUSIONS

The study showed that anticholinergic and sedative medication exposure measured by DBI was associated with higher levels of dependency on the Katz ADL index in a sample of older adults with psychiatric illnesses from an aged-care home.

摘要

背景

具有抗胆碱能和/或镇静特性的药物常用于精神疾病的治疗。抗胆碱能和镇静药物使用负担已通过药物负担指数(DBI)评分工具进行衡量。较高的DBI评分与跌倒、骨骼和髋部骨折风险增加以及功能和认知障碍等其他严重健康后果相关,尤其是在老年人中。

目的

我们旨在使用DBI描述患有精神疾病的老年人的药物负担,确定与DBI测量的药物负担相关的因素,并研究DBI评分与日常生活活动(ADL)指数的Katz评分之间的关联。

方法

在一家老年护理院的老年精神科进行了一项横断面研究。研究样本包括所有年龄≥65岁、被诊断患有精神疾病的住院患者。获得的数据包括人口统计学特征、住院时间、主要精神疾病诊断和合并症、使用Katz ADL指数评估的功能状态以及使用简易精神状态检查表(MMSE)评分评估的认知状态。计算每种使用的抗胆碱能和镇静药物的DBI评分。

结果

在200名符合分析条件的患者中,106名(53.1%)为女性,平均年龄为76±9岁。最常见的慢性疾病是高血压102例(51%)和精神分裂症94例(47%)。163名(81.5%)患者使用了具有抗胆碱能和/或镇静作用的药物;平均DBI评分为1.25±1。多项逻辑回归结果显示,与DBI评分为0相比,精神分裂症(优势比(OR)=2.1(95%置信区间(CI)1.57 - 4.45),p = 0.01)、依赖程度(OR = 3.50(95%CI 1.38 - 5.70),p = 0.001)和多重用药(OR = 2.99(95%CI 2.15 - 4.29),p = 0.003)与DBI评分≥1显著相关。

结论

该研究表明,在一家老年护理院患有精神疾病的老年人样本中,通过DBI测量的抗胆碱能和镇静药物暴露与Katz ADL指数的较高依赖水平相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/10232684/c1c5e0a2d4c2/40801_2023_357_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验